Motley FoolNovartis Hopes to Have Another COVID Therapy on the WayRead full articleKeith Speights and Brian Orelli, PhD, The Motley FoolJanuary 23, 2022 at 2:28 a.m.·2 min readNovartis and Molecular Partners reported positive results for COVID-19 candidate ensovibep.Continue reading